AOD-9604 actually completed a phase 2b. Nobody talks about what it found

Here is a thing I find revealing. AOD-9604 is one of very few compounds on this site with a completed human efficacy trial — a real phase 2b, marked evidence: early.

And it is far less discussed than HGH Frag 176-191, its parent molecule, which is evidence: none.

The one with the answer is less popular than the one without.

Because the answer was disappointing, and that is the whole mechanism.

A compound with a completed trial has a ceiling. A compound without one has whatever ceiling you can imagine for it. Marketing prefers the second and so, honestly, do buyers.

Development attention moved on to cartilage and joint indications, which is what happens when the original hypothesis does not deliver enough to carry a programme.

Worth being precise rather than cynical, because the trial did establish something real and positive.

The design idea is elegant: the fat-metabolising activity of growth hormone was thought to sit in the C-terminal fragment, separate from the growth-promoting and glucose-disrupting activity. So take the tail, leave the rest. If it works you get the fat loss without the insulin antagonism.

The trial supported the safety half of that. No signal of the blood sugar problems growth hormone causes, well tolerated. That is a genuine finding and it distinguishes it from everything upstream in the GH category.

What it did not deliver was efficacy at a level that justified continuing.

Which makes it an unusually informative compound to have on the site. It is the control case: this is what it looks like when one of these actually gets tested.

And what it looks like is "safe, elegant, and not enough".

Meanwhile the parent fragment is sold on the strength of the child's trial, which is the TB-500 problem again — human data for a related molecule being cited for the one in the vial.

Except here it is even better, because the related molecule's trial was the disappointing one. The data being borrowed is data that did not work.